Literature DB >> 24863086

[The effect of sibutramine on weight loss in obese adolescents].

Ruth Rocha Franco1, Louise Cominato1, Durval Damiani1.   

Abstract

OBJECTIVE: To evaluate the effect of sibutramine on weight loss in obese adolescents. SUBJECTS AND METHODS: A double-blind controlled study lasting 13 months. The study included 73 obese adolescents of both sexes aged between 10 and 18 years. Laboratory tests and imaging studies were performed before, during wash-out, and at the end of 13 months.
RESULTS: The percentage of patients who lost 10% of their initial weight in the placebo group was 46%, and in the sibutramine group was 75%. When placebo was used, average weight rose by 1.61 kg, and BMI decreased by 0.24 kg/m(2) whereas with the use of sibutramine, weight decreased by 4.47 kg, and average BMI decreased, 2.38 kg/m(2), with p < 0.001.
CONCLUSIONS: Sibutramine induced significantly more weight loss in obese adolescents compared with placebo, without significant side effects. The weight loss curve was different depending on the moment sibutramine was introduced. This finding indicates that the best time to start sibutramine is when adhesion begins to fail.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24863086     DOI: 10.1590/0004-2730000002825

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  1 in total

Review 1.  Drug interventions for the treatment of obesity in children and adolescents.

Authors:  Emma Mead; Greg Atkinson; Bernd Richter; Maria-Inti Metzendorf; Louise Baur; Nicholas Finer; Eva Corpeleijn; Claire O'Malley; Louisa J Ells
Journal:  Cochrane Database Syst Rev       Date:  2016-11-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.